The aim of the Amgen Scholars Program is to inspire the scientists of tomorrow and to offer opportunities to learn hands-on in labs and to reflect on how to achieve a successful career in research.

Working as part of a research team under the supervision of an assigned faculty mentor, you will have the opportunity to learn from leading scientists and carry out a project. The research project ...

MISSOULA, Mont. — Montana Tech will bestow Distinguished Alumni Awards upon three individuals tonight. This year's honorees include: Stacy Aguirre (A.S. Engineering ...

Caltech researchers have reintroduced a classic technique to image the formation and growth of individual cells that make up biofilms, sticky masses of millions of cells that are often responsible for ...

Findings point to importance of RSV vaccination in older patients with systemic autoimmune rheumatic diseases.

Caltech researchers have reintroduced a classic technique to image the formation and growth of individual cells that make up biofilms, sticky masses ...

LOS ANGELES, Oct 6 (Reuters) - Amgen (AMGN.O), opens new tab on Monday launched direct-to-consumer U.S. sales of its cholesterol-lowering medication Repatha at a discounted cash price, becoming the ...

Amgen AMGN announced the launch of a new direct-to-consumer (DTC) program called AmgenNow, which will offer significant discounts on its marketed drugs. The company has initiated this DTC program with ...

LOS ANGELES (Reuters) -Amgen on Monday launched direct-to-consumer U.S. sales of its cholesterol medication Repatha at a discounted cash price, becoming the latest pharmaceutical company responding to ...

AmgenNow, a direct-to-patient program, launches with Repatha, following positive Phase III Vesalius-CV trial results showing reduced cardiovascular events. Starting October 6, 2025, AmgenNow will be ...

Amgen's weight management candidate looks very promising. The large biotech boasts a deep pipeline beyond that segment. Amgen's dividend looks great, and the stock is reasonably valued. Even so, there ...